The correct answer is D. Human insulin. The first product to be commercially produced using recombinant DNA technology was human insulin. In 1982, Eli Lilly and Company and Genentech received approval from the U.S. Food and Drug Administration (FDA) to market and sell human insulin synthesized through recombinant DNA techniques. This achievement revolutionized the treatment of diabetes and marked a significant milestone in the field of biotechnology.